US$ 23.52
ascendis pharma glp-1 receptor agonist medications Emerging Trends in the Development of GLP-1 Receptor Agonists A schematic overview of GLP-1
Description
Example code lists used to identify covariates are included in supplementary table S2
DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect

Read insights by ProspHire.

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

Glucagon-like peptide 1 (GLP-1) is a cleavage product of the pre-proglucagon gene which is expressed in the -cells of the pancreas, the L-cells of the intestine, and neurons located in the caudal brainstem and hypothalamus
